Results 101 to 110 of about 182,561 (302)

Editorial: Wild plant genetic resources: a hope for tomorrow. [PDF]

Front Plant Sci, 2023
Khan MK, Islam T, Gezgin S, Di Gioia F.
europepmc   +1 more source

Cell‐cycle‐specific lesion evolution rather than inhibition of double‐strand‐break repair underpins cisplatin radiosensitization

Molecular Oncology, EarlyView.
We analyze cisplatin–DNA adducts (CDAs) and double‐strand breaks (DSBs) in a cell‐cycle‐dependent manner. We find that CDAs form similarly across all cell cycle phases. DSBs arise only in S‐phase. CDAs might not directly impair DSB repair, but S‐phase DSB lesions evolve in the presence of CDAs and disrupt repair in G2, also causing radiosensitization ...
Ye Qiu, Xixi Lin, Emil Mladenov, Veronika Mladenova, Jürgen Thomale, Ali Sak, Yao Wang, Yunxuan Deng, Eleni Gkika, Martin Stuschke, George Iliakis   +10 more
wiley   +1 more source

What Plant Genetic Resources for Food and Agriculture Are Available under the Plant Treaty and Where Is This Information? [PDF]

Plants (Basel), 2023
Gullotta G, Engels JMM, Halewood M.
europepmc   +1 more source

Conservation of Plant Genetic Resources

, 2023
Cilj je udžbenika „Očuvanje biljnih genetskih izvora“ objasniti teorijske i praktične aspekte očuvanja i održive upotrebe biljnih genetskih izvora. Proizvodnja hrane i drugih poljoprivrednih proizvoda temelji se na raspoloživosti biljnih genetskih izvora koji se koriste u svrhu oplemenjivanja novih, visokoprinosnih kultivara visoke kakvoće te otpornih ...
Varga, Filip, Grdiša, Martina, Jeran, Nina, Šatović, Zlatko   +3 more
openaire  

Changing Responsibilities and Roles for Plant Genetic Resources within the CGIAR System

, 1992
A paper prepared by IBPGR (in transition to becoming IPGRI) describing the process by which the various elements of the CGIAR System had thus far considered the definitions of their roles in relation to plant genetic resources. It reviews the opinions of
International Board for Plant Genetic Resources
core  

Interaction of HS1BP3 with cortactin modulates TKS5 localisation, cell secretion and cancer malignancy

Molecular Oncology, EarlyView.
Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen, Kristiane Søreng, Chiara Veroni, Laura Trachsel‐Moncho, Nagham Asp, Robin Gaupset, Lars Gustav Lyckander, Helene Knævelsrud, Lars Eftang, Anne Simonsen   +9 more
wiley   +1 more source

Nutritional value of Vigna unguiculata (L.) Walp. accessions with different seed color

Биотехнология и селекция растений
Background. Cowpea Vigna unguiculata (L.) Walp. has long been a cultivated crop in Africa, Southeast Asia, and the Americas. Cowpea seeds are renowned for their delicious flavor and high protein, carbohydrate, macro- and micronutrient content, and ...
V. S. Popov, А. A. Nikiforov, E. E. Safonova, T. V. Shelenga, E. A. Krylova, M. O. Burlyaeva   +5 more
doaj   +1 more source

Improving the use of plant genetic resources to sustain breeding programs' efficiency. [PDF]

Proc Natl Acad Sci U S A, 2023
Sanchez D, Sadoun SB, Mary-Huard T, Allier A, Moreau L, Charcosset A.   +5 more
europepmc   +1 more source

Diversity for development: the new strategy of the International Plant Genetic Resources Institute

, 2019
In 1993, IPGRI published its first strategy as a new institute. The original Diversity for Development was written in the context of a world that had only come to grips with the connection between environment and development. The strategy described IPGRI'
International Plant Genetic Resources Institute, European Cooperative Programme for Plant Genetic Resources   +1 more
core  

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source